[Treatment of human strongyloidiasis with a new antihelmintic, cambendazole. Double-blind study].
D000293:Adolescent; D000328:Adult; D001562:Benzimidazoles / Q000627:therapeutic use*; D002159:Cambendazole / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013322:Strongyloidiasis / Q000188:drug therapy*
D001562:Benzimidazoles; D002159:Cambendazole
Tratamento da estrongiloidíase humana com novo anti-helmíntico, o cambendazole. Estudo duplo cego.